Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2023 ASCO Gastrointestinal Cancers Symposium
2022 Lynn Sage Breast Cancer Symposium
2022 ASH Annual Meeting and Exposition
2022 San Antonio Breast Cancer Symposium
13th European Breast Cancer Conference
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2016 ASH Annual Meeting
«
1
»
Advertisement
Advertisement
Feb
01
Today In Oncology
First-Line NALIRIFOX Regimen Improves Overall Survival in Metastatic Pancreatic Cancer
Subset of Patients With Advanced Gastric/GEJ Cancer May Benefit From CLDN18.2-Targeted Drug Zolbetuximab
Momelotinib May Effectively Reduce Anemia and Other Symptoms for Patients With Myelofibrosis
Subcutaneous Epcoritamab for Relapsed or Refractory Large B-Cell Lymphoma
FDA Approves Mosunetuzumab-axgb, a First-in-Class Bispecific Antibody, in Relapsed or Refractory Follicular Lymphoma
View More
Advertisement
